Coherus BioSciences
CHRS
$2.05
Share price
0.49%
Change (1 day)
-71.65%
Change (1 year)
Categories
Coherus BioSciences (CHRS) - Cash on Hand
Cash on Hand as of December 2023 : $0.11 B
According to Coherus BioSciences
's latest financial reports the company has $0.11 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Coherus BioSciences - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.19 B | -54.05% |
| 2021-12-31 | $0.41 B | -22.91% |
| 2020-12-31 | $0.54 B | 204.59% |
| 2019-12-31 | $0.17 B | 145.55% |
| 2018-12-31 | $72.35 M | -42.99% |
| 2017-12-31 | $0.12 B | 1.57% |
| 2016-12-31 | $0.12 B | -21.03% |
| 2015-12-31 | $0.15 B | 5.21% |
| 2014-12-31 | $0.15 B | 280.22% |
| 2013-12-31 | $39.55 M | 171.89% |
| 2012-12-31 | $14.54 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $10.94 B | 9,194.43% | 🇺🇸 USA |
 Repligen
RGEN | $0.75 B | 538.08% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $29.97 M | -74.54% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |